Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Silo Pharma ( (SILO) ) has issued an announcement.
On July 29, 2025, Silo Pharma, Inc. entered into an asset purchase agreement with MAVS Holdings LLC to acquire certain software and domain names, including r2crypto.com, in exchange for 750,000 shares of its common stock. This acquisition is expected to enhance Silo Pharma’s digital asset portfolio and market presence, potentially impacting its operations and positioning within the industry.
More about Silo Pharma
Average Trading Volume: 1,098,282
Technical Sentiment Signal: Sell
Current Market Cap: $4.8M
For a thorough assessment of SILO stock, go to TipRanks’ Stock Analysis page.